Blocking the activin IIB receptor with bimagrumab ( BYM338 ) increases walking performance: A meta‐analysis-Reference-Cited by-同舟云学术

Blocking the activin IIB receptor with bimagrumab ( BYM338 ) increases walking performance: A meta‐analysis

Published:2021-08-17 Issue:10 Volume:21 Page:939-943
ISSN:1444-1586
Container-title:Geriatrics & Gerontology International
language:en
Short-container-title:Geriatr. Gerontol. Int.

Author:

Spitz Robert W.¹,Dankel Scott J.²,Bell Zachary W.¹,Wong Vickie¹,Abe Takashi¹^ORCID,Kang Minsoo³,Loenneke Jeremy P.¹^ORCID

Affiliation:

1. Department of Health, Exercise Science, and Recreation Management, Kevser Ermin Applied Physiology Laboratory The University of Mississippi University Mississippi USA

2. Exercise Physiology Laboratory, Department of Health and Exercise Science Rowan University Glassboro New Jersey USA

3. Department of Health, Exercise Science, and Recreation Management, Health and Sport Analytics Laboratory The University of Mississippi University Mississippi USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ggi.14265

Reference19 articles.

1. Strength is a major factor in balance, gait, and the occurrence of falls;Wolfson L;J Gerontol A Biol Sci Med Sci,1995

2. Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults

3. Home-Based Resistance Training: Predictors of Participation and Adherence

4. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy

5. Long-term safety and tolerability of bimagrumab (BYM338) in sporadic inclusion body myositis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistically Acting on Myostatin and Agrin Pathways Increases Neuromuscular Junction Stability and Endurance in Old Mice;Aging and disease;2023

2. Mechanisms of sarcopenia in liver cirrhosis and the role of myokines;Annals of Gastroenterology;2023

3. Mendelian randomization of circulating proteome identifies actionable targets in heart failure;BMC Genomics;2022-08-13

4. Turning the clock forward: New pharmacological and non pharmacological targets for the treatment of obesity;Nutrition, Metabolism and Cardiovascular Diseases;2022-06